Effects of umbelliferone isolated from the Ferulago pauciradiata Boiss. & Heldr. Plant on cecal ligation and puncture-induced sepsis model in rats
Özet
Sepsis is a pathophysiological event involving systemic inflammatory response syndrome, multiple organ failure syndromes, and tissue damage. Overproduction of free radicals as a result of tissue damage during sepsis contributes to cellular toxicity, organ failure, and even mortality. Antioxidants, which scavenge free radicals, play a protective role against various diseases. Previous studies have shown that umbelliferone (UF) has antioxidant and anti-inflammatory effects. Since oxidative stress is naturally associated with sepsis-induced organ dysfunction, the application of antioxidant compounds could potentially illuminate the pathophysiology of sepsis, which does not yet have an effective treatment. The sepsis model induced by cecal ligation and puncture (CLP) was applied to rats. Different doses of UF (10░mg/kg, 20░mg/kg, and 40░mg/kg) on oxidant-antioxidant in septic rats, mRNA of inflammatory mediators such as tumor necrosis factor- α (TNF-α) and interleukin (IL)-1 its effects on expression levels were evaluated in lung, kidney, and liver tissues. When the lung, kidney, and liver tissues of septic rats were compared with those of the control group, it was found that UF administration increased dose-dependent superoxide dismutase activity and glutathione levels and significantly decreased malondialdehyde levels. The effects of UF administration on oxidative parameters were dose-dependent. The 40░mg/kg UF dose showed greater anti-oxidative properties than the 20░mg/kg and 10░mg/kg doses for all the evaluated parameters. Further, the TNF- α mRNA expression of the CLP +40░mg/kg group was reduced to a level comparable to that of the control group. UF has been found to be an effective molecule in reducing oxidative stress by supporting endogenous antioxidants and enhancing the scavenging effects of free radicals. The potent antioxidant property of UF may also be related to the suppression of the cytokine cascade during sepsis. The results suggest that UF administration may represent a new treatment for the prevention of lung, kidney and liver damage caused by septic conditions.
Anahtar Kelimeler
- Scopus
- 22
- WoS
- 21
- OpenAlex
- 23
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Kutlu, Z. | |
| dc.contributor.author | Celik, M. | |
| dc.contributor.author | Bilen, A. | |
| dc.contributor.author | Halıcı, Z. | |
| dc.contributor.author | Yıldırım, S. | |
| dc.contributor.author | Karabulut, S. | |
| dc.contributor.author | Karakaya, S. | |
| dc.contributor.author | Bostanlık, Delimustafaoğlu F. | |
| dc.contributor.author | Aydın, P. | |
| dc.date.accessioned | 2026-10-29T19:09:03.832659906Z | |
| dc.date.available | 2026-10-29T19:09:03.832659906Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Sepsis is a pathophysiological event involving systemic inflammatory response syndrome, multiple organ failure syndromes, and tissue damage. Overproduction of free radicals as a result of tissue damage during sepsis contributes to cellular toxicity, organ failure, and even mortality. Antioxidants, which scavenge free radicals, play a protective role against various diseases. Previous studies have shown that umbelliferone (UF) has antioxidant and anti-inflammatory effects. Since oxidative stress is naturally associated with sepsis-induced organ dysfunction, the application of antioxidant compounds could potentially illuminate the pathophysiology of sepsis, which does not yet have an effective treatment. The sepsis model induced by cecal ligation and puncture (CLP) was applied to rats. Different doses of UF (10░mg/kg, 20░mg/kg, and 40░mg/kg) on oxidant-antioxidant in septic rats, mRNA of inflammatory mediators such as tumor necrosis factor- α (TNF-α) and interleukin (IL)-1 its effects on expression levels were evaluated in lung, kidney, and liver tissues. When the lung, kidney, and liver tissues of septic rats were compared with those of the control group, it was found that UF administration increased dose-dependent superoxide dismutase activity and glutathione levels and significantly decreased malondialdehyde levels. The effects of UF administration on oxidative parameters were dose-dependent. The 40░mg/kg UF dose showed greater anti-oxidative properties than the 20░mg/kg and 10░mg/kg doses for all the evaluated parameters. Further, the TNF- α mRNA expression of the CLP +40░mg/kg group was reduced to a level comparable to that of the control group. UF has been found to be an effective molecule in reducing oxidative stress by supporting endogenous antioxidants and enhancing the scavenging effects of free radicals. The potent antioxidant property of UF may also be related to the suppression of the cytokine cascade during sepsis. The results suggest that UF administration may represent a new treatment for the prevention of lung, kidney and liver damage caused by septic conditions. | |
| dc.identifier.articlenumber | 110206 | |
| dc.identifier.doi | 10.1016/j.biopha.2020.110206 | |
| dc.identifier.eissn | 1950-6007 | |
| dc.identifier.issn | 0753-3322 | |
| dc.identifier.pmid | 32407990 | |
| dc.identifier.scopus | 2-s2.0-85084377191 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/bayburt/11997 | |
| dc.identifier.volume | 127 | |
| dc.identifier.wos | WOS:000543493200087 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Masson SAS | |
| dc.relation.ispartof | Biomedicine and Pharmacotherapy | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Antioxidant | |
| dc.subject | CLP | |
| dc.subject | IL-1 | |
| dc.subject | TNF-α | |
| dc.subject | Umbelliferone | |
| dc.subject.classification | Medicine, Research & Experimental | |
| dc.subject.classification | Pharmacology & Pharmacy | |
| dc.subject.classification | Research & Experimental Medicine | |
| dc.subject.other | Animals | |
| dc.subject.other | Antioxidants | |
| dc.subject.other | Apiaceae | |
| dc.subject.other | Cytokines | |
| dc.subject.other | Disease Models, Animal | |
| dc.subject.other | Dose-Response Relationship, Drug | |
| dc.subject.other | Free Radical Scavengers | |
| dc.subject.other | Oxidative Stress | |
| dc.subject.other | Rats | |
| dc.subject.other | Rats, Wistar | |
| dc.subject.other | Sepsis | |
| dc.subject.other | Umbelliferones | |
| dc.subject.other | glutathione | |
| dc.subject.other | interleukin 1 | |
| dc.subject.other | malonaldehyde | |
| dc.subject.other | messenger RNA | |
| dc.subject.other | superoxide dismutase | |
| dc.subject.other | tumor necrosis factor | |
| dc.subject.other | umbelliferone | |
| dc.subject.other | antioxidant | |
| dc.subject.other | cytokine | |
| dc.subject.other | scavenger | |
| dc.subject.other | umbelliferone derivative | |
| dc.subject.other | animal experiment | |
| dc.subject.other | animal model | |
| dc.subject.other | animal tissue | |
| dc.subject.other | antioxidant activity | |
| dc.subject.other | cecal ligation and puncture-induced sepsis | |
| dc.subject.other | controlled study | |
| dc.subject.other | dose response | |
| dc.subject.other | enzyme activity | |
| dc.subject.other | Ferulago pauciradiata | |
| dc.subject.other | histopathology | |
| dc.subject.other | immunohistochemistry | |
| dc.subject.other | kidney tissue | |
| dc.subject.other | lipid peroxidation | |
| dc.subject.other | liver tissue | |
| dc.subject.other | lung parenchyma | |
| dc.subject.other | mRNA expression level | |
| dc.subject.other | nonhuman | |
| dc.subject.other | priority journal | |
| dc.subject.other | rat | |
| dc.subject.other | Review | |
| dc.subject.other | animal | |
| dc.subject.other | chemistry | |
| dc.subject.other | disease model | |
| dc.subject.other | drug effect | |
| dc.subject.other | isolation and purification | |
| dc.subject.other | metabolism | |
| dc.subject.other | pathophysiology | |
| dc.subject.other | Wistar rat | |
| dc.title | Effects of umbelliferone isolated from the Ferulago pauciradiata Boiss. & Heldr. Plant on cecal ligation and puncture-induced sepsis model in rats | |
| dc.type | Review Article | |
| rdl.citation.openalex | 23 | |
| rdl.citation.scopus | 22 | |
| rdl.citation.wos | 21 | |
| rdl.department | Department of Biochemistry, Faculty of Pharmacy, Atatürk University, Erzurum, 25240, Turkey | |
| rdl.department | Department of Biochemistry, Faculty of Medicine, Atatürk University, Erzurum, 25240, Turkey | |
| rdl.department | Department of Internal Medicine, Faculty of Medicine, Atatürk University, Erzurum, 25240, Turkey | |
| rdl.department | Faculty of Medicine, Department of Pharmacology, Atatürk University, Erzurum, 25240, Turkey | |
| rdl.department | Clinical Research, Development and Design Application and Research Center, Ataturk University, 25240, Erzurum, Turkey | |
| rdl.department | Department of Pathology, Faculty of Veterinary Medicine, Ataturk University, Erzurum, 25240, Turkey | |
| rdl.department | Health Services Vocational School, Bayburt University, Bayburt, 69000, Turkey | |
| rdl.department | Department of Pharmacognosy, Faculty of Pharmacy, Ataturk University, Erzurum, 25240, Turkey | |
| rdl.department | Department of Pharmaceutical Botany, Faculty of Pharmacy, Ankara University, Ankara, 06000, Turkey | |
| rdl.department | Department of Anesthesia, Regional Education and Research Hospital, Erzurum, 25240, Turkey | |
| rdl.oa.status | gold | |
| rdl.oa.url | https://doi.org/10.1016/j.biopha.2020.110206 | |
| rdl.scopus.quartile | Q1 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

